10x Insights
Loading account…
Companies / Healthcare / Medline Inc.
MDLN

Medline Inc.

HealthcareSurgical & Medical Instruments
Ticker MDLNNORTHFIELD, ILFiscal year ends DecemberBook value per share $13.26Diluted shares 810.0M

Medline Inc. (Nasdaq: MEDL) is the largest provider of medical-surgical products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Founded in 1966, the company delivers mission-critical products used daily across the full range of care settings, from hospitals and… From the company’s description.

Fiscal year 2025 · ends 12-31
Sales & profitability
$28.43B
7.78%
10.79%
Cash & financing
$1.74B
$1.30B
1.17
810.0M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Medline Inc. does

In the company’s own words

Medline Inc. (Nasdaq: MEDL) is the largest provider of medical-surgical products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Founded in 1966, the company delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. The company's website is www.medline.com.

Medline operates through two reportable segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment offers approximately 190,000 med-surg products organized into three categories: Front Line Care, which includes wound care, exam gloves, skin care, incontinence products, and infection control supplies; Surgical Solutions, encompassing operating room products, surgical procedure trays, personal protective equipment, and orthopedic implants; and Laboratory and Diagnostics, providing point-of-care testing, analyzers, and diagnostic consumables. The Supply Chain Solutions segment distributes approximately 145,000 products from over 1,300 third-party suppliers, including leading national brands, while also providing supply chain optimization services such as consulting, outsourced warehouse management, and logistics solutions.

The company's differentiated business model centers on its Prime Vendor relationships, which are multi-year distribution agreements whereby customers consolidate their med-surg purchasing with Medline. This model has achieved a greater than 98% average Prime Vendor retention rate over the past five years. Medline operates a network of 70 global distribution centers, warehouses, and transship facilities, with 45 located in the United States, enabling next-day delivery to 95% of the U.S. customer base. The company operates its own fleet of more than 2,100 MedTrans trucks and employs over 45,000 employees worldwide, with more than 26,000 in the United States.

Medline manufactures approximately one-third of its Medline Brand products through 30 manufacturing facilities, primarily in North America, while sourcing the remaining two-thirds from a network of more than 600 global partners across approximately 40 countries. The company holds more than 2,300 granted patents and maintains notable brands including Medline, Curad, Microtek, Hudson, and Proxima. Medline's commercial platform includes approximately 4,000 U.S. sales and support personnel dedicated to driving efficiencies across all points of care.

Company details
Sector
Healthcare
Industry
Surgical & Medical Instruments
Headquarters
NORTHFIELD, IL
Fiscal year end
December
CIK
2046386
SIC
3841

Financial performance, year by year

Fiscal 2025–2025 · USD
$-2.84B$5.69B$14.22B$22.75B$31.28B2025

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Medline Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

359
funds hold it
1 of 35
superinvestors hold it
$7.31B
held by funds, at market
21.5%
of shares held by funds

Superinvestors in Medline Inc. · what they did last quarter

Stephen MandelINCREASED +77.9%
Lone Pine Capital
5.1%of 13F portfolio

Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.

Largest fund holders · Medline Inc.’s weight in each

0.60%of fund net assets
0.31%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.02%of fund net assets
VANGUARD MID-CAP INDEX FUND
VO · VANGUARD INDEX FUNDS
0.15%of fund net assets
0.09%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • How do Medline Inc. and its peers compare on margins and cash generation over ten years?
  • Where did five years of Medline Inc.'s earnings go — cash, debt, buybacks, reinvestment?
  • What changed in Medline Inc.'s last four quarterly filings that the numbers alone won't show?
See how it works →All research tools with a subscription. Use your own AI account.